BLOG
FDA Proposed Rules Review, Part 3 of 4: WDD Licensing Standards & Approved Organizations Oversight
FDA Proposed Rules Review, Part 3 of 4: WDD Licensing Standards & Approved Organizations Oversight Written-by: Sumeet Singh, CEO In this third part of the review of FDA’s proposed rules, we focus on the national standards FDA seeks to levy on Wholesale Drug...
Recent Articles
Teva Pharmaceuticals Earns VAWD Reaccreditation!
Teva Pharmaceuticals Earns VAWD Reaccreditation! We are excited to announce that our client, Teva Pharmaceuticals, was awarded VAWD® Reaccreditation...
A New Take on Vertical Integration: Hospital System Start Manufacturing Drugs
A New Take on Vertical Integration: Hospital System Start Manufacturing Drugs Background Pharma Solutions first released the story of the four major...
FDA Begins DSCSA Enforcement on Distributors
FDA Begins DSCSA Enforcement on Distributors The first-time inspection of a wholesale drug distributor for DSCSA requirements is a warning to...
PBMs Under Fire
PBMs Under Fire PBMs grew with conviction over the past decade but the tide has begun to turn: state and federal government, as well as PBM...
NABP / Optum Rx VAWD Lawsuit
NABP / Optum Rx VAWD Lawsuit Three generic drug wholesalers, Oak Drugs (“Oak”), Matrix Distributors (“Matrix”), and Primed Pharmaceuticals...
State of the Union Address: A Look Back & Forward
State of the Union Address: A Look Back & Forward Looking Back It is everyone’s favorite time of year! With the holiday season in full swing, we...
